Search for: "Merck & Co, Inc. v. United States" Results 1 - 20 of 168
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2024, 11:33 am by admin
A few months after the Oregon hearings, Judge Weinstein, in the fall of 1996, along with other federal and state judges, held a “Daubert” hearing on the admissibility of expert witness opinion testimony in breast implant cases, pending in New York state and federal courts. [read post]
5 Jan 2022, 4:33 am by Jon L. Gelman
COVID is the most extensive occupational exposure event in the history of the United States. [read post]
21 Sep 2020, 12:41 pm by Rebecca Tushnet
Finally, Diamond tried to get the court to adopt the rule of Novartis Consumer Health, Inc. v. [read post]
11 Sep 2019, 1:00 pm by Oswin Ridderbusch
The specific DP IV inhibitor sitagliptin as such, however, is not identified in Royalty Pharma’s basic patent as it was developed only after the filing date of the patent (and gave rise to a distinct patent filed by Merck & Co., Inc.). [read post]
30 Aug 2019, 6:31 am
Interestingly, Canadian courts used to follow the British approach but, in its recent decision in Merck & Co. v. [read post]
8 Mar 2019, 5:00 am by Brian Corcoran
Their argument cited ongoing litigation in Mondelez International, Inc. v. [read post]
14 Feb 2018, 2:57 pm by Kevin LaCroix
CalPERS appealed, asserting that its individual suit was timely because the three-year time limit was subject to equitable tolling pursuant to American Pipe & Construction Co. v. [read post]
3 Mar 2017, 7:25 am
  The judge also cautioned that the purpose of the declarations in the present proceedings is different to the motivations for the declarations sought in Arrow Generics Limited v Merck & Co. [read post]